Advertisement

Picture Eurasanté BioFIT 2017 Strasbourg France November 600x60px
Document › Details

Bruker Corporation. (4/27/17). "Press Release: Bruker Corporation to Present at the 42nd Annual Deutsche Bank Health Care Conference". Billerica, MA.

Region Region Boston, MA
  Country United States (USA)
Organisations Organisation Bruker Corporation (Nasdaq: BRKR)
  Group Bruker Corporation (Group)
  Organisation 2 Deutsche Bank (Group)
Products Product Deutsche Bank Annual Health Care Conference 2017 Boston
  Product 2 analytical instrument
Index term Index term Bruker Corp–Deutsche Bank: investor conference, 201705 supply service Bruker presents at Deutsche Bank Annual Health Care Conference
Persons Person Laukien, Frank H. (Bruker 201204 President + CEO)
  Person 2 Minkova, Miroslava (Bruker Corp 201611 Head of Investor Relations)
     


Bruker Corporation (NASDAQ: BRKR) announced today it will present at the 42nd annual Deutsche Bank Health Care Conference at The InterContinental Hotel, 510 Atlantic Avenue, Boston. Frank Laukien, Chairman, President & CEO will participate in a "fireside chat" Q&A session on behalf of the company on Thursday, May 4th, 2017 at 8:40 AM Eastern Time.

A live audio webcast of the presentation will be available on the Investor section of the Company's Web site at http://ir.bruker.com. A replay of the presentation will be posted on the Bruker Corporation website after the event and will be available for 30 days following the presentation.


About Bruker Corporation

For more than 55 years, Bruker has enabled scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker's high-performance scientific instruments and high-value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular and microscopic levels.

In close cooperation with our customers, Bruker is enabling innovation, productivity and customer success in life science molecular research, in applied and pharma applications, in microscopy, nano-analysis and industrial applications, as well as in cell biology, preclinical imaging, clinical phenomics and proteomics research, clinical microbiology and molecular pathology research. For more information, please visit: www.bruker.com


Contact:

Miroslava Minkova Head of Investor Relations
Bruker Corporation
T: +1 (978) 663 – 3660, ext. 1479
miroslava.minkova@bruker.com

   
Record changed: 2017-07-02

Advertisement

Picture EBD Group Bio-Europe 2017 BEU Berlin Germany November 600x60px

More documents for Bruker Corporation (Group)


To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

Picture Eurasanté BioFIT 2017 Strasbourg France November 600x60px




» top

Advertisements

Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture EBD Group Bio-Europe 2017 BEU Berlin Germany November 120x80px Picture Eurasanté BioFIT 2017 Strasbourg France November 120x80px Picture EBD Group Bio-Europe 2017 BEU Berlin Germany November 120x80px Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px Banner Fairtec GmbH Solutions for Smarter Business Events Exhibitions 120x120px Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture Eurasanté BioFIT 2017 Strasbourg France November 120x80px Picture EBD Group Bio-Europe 2017 BEU Berlin Germany November 120x80px